# Niki BioSolutions, Inc. (NIKI)

Source page: https://stoqly.net/companies/niki

- **Ticker:** NIKI (Nasdaq)
- **Sector:** Information Technology / Measuring & Controlling Devices, Nec
- **SEC CIK:** 0001734005
- **Latest annual report:** 20-F filed 2026-03-27 (https://www.sec.gov/Archives/edgar/data/1734005/000121390026035484/ea0281612-20f_aptorum.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $1.77 on 2026-10-30
- **Market cap:** $13.0M
- **EPS, trailing 12 months:** −$0.19
- **Return on equity:** −6.2%
- **Change in share count:** +34.8%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/niki/figures.csv

| US$ millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | — | — | — | 2 | 1 | 0 | — | — |
| Net income | -15 | -20 | 5 | -25 | -10 | -3 | -4 | -1 |
| Diluted EPS (US$) | -0.53 | -0.64 | 2.00 | -7.15 | -2.75 | -0.62 | -0.78 | -0.19 |
| Operating cash flow | -10 | -13 | -16 | -15 | -12 | -8 | -1 | -2 |
| Free cash flow | -16 | -14 | -16 | -15 | -13 | -8 | — | — |
| Cash | 13 | 6 | 4 | 8 | 5 | 2 | 1 | 3 |
| Debt and leases | 3 | 0 | 0 | 0 | 0 | — | — | — |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.